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Low–molecular-weight metabolites produced by intestinal microbiota play a direct role in health and
disease. In this study, we analyzed the colonic luminal metabolome using capillary electrophoresis mass
spectrometry with time-of-flight (CE-TOFMS) —a novel technique for analyzing and differentially
displaying metabolic profiles— in order to clarify the metabolite profiles in the intestinal lumen.
CE-TOFMS identified 179 metabolites from the colonic luminal metabolome and 48 metabolites were
present in significantly higher concentrations and/or incidence in the germ-free (GF) mice than in the
Ex-GF mice (p , 0.05), 77 metabolites were present in significantly lower concentrations and/or incidence
in the GF mice than in the Ex-GF mice (p , 0.05), and 56 metabolites showed no differences in the
concentration or incidence between GF and Ex-GF mice. These indicate that intestinal microbiota highly
influenced the colonic luminal metabolome and a comprehensive understanding of intestinal luminal
metabolome is critical for clarifying host-intestinal bacterial interactions.
A
tleast1,000bacterialspecieshavebeenfoundtoinhabitthehumanintestine,and10
14individualbacterial
cells of atleast 160different speciesinhabit each individual’s intestine
1,whichis 10timesgreater than the
total number of somatic and germ cells in the human body. Intestinal microbiota play a fundamentally
important role in health and disease such as inflammatory bowel disease
2, allergy
3,4, and colon cancer
5. Recently,
the relationship between intestinal microbiota and systemic phenomena, such as obesity
6 and autism
7 have been
reported. The lifespan of germ-free (GF) mice is longer than that of conventional mice
8, showing that intestinal
microbiotacontributetolifespan.Inthelatterhalfofthe1990s,manymolecular-biologicalapproachesusing16S
rRNA gene sequencing have been performed for the analysis of intestinal microbiota
9. More recently, metage-
nomic techniques have been used to characterize both the composition and the potential physiological effects of
themicrobialcommunity(microbiome)
10,11.Somereportshavedemonstratedthatthegutmicrobiomeinfluences
the metabolic profiling of organs, blood, and urine of the host
12,13.
Low–molecular-weight metabolites produced by intestinal microbiota are absorbed constantly from the
intestinal lumen and carried to systemic circulation; they play a direct role in health and disease. There are
few reports concerning the function of metabolites produced by intestinal microbiota. At present, some research
studies are targeting specific metabolites, such asshort chain fattyacids (SCFAs)
14and polyamines (PAs)
15,16, but
not global metabolites (metabolome). Metabolomics is the rapidly evolving field of the comprehensive measure-
ment of, ideally, all metabolites in a biological fluid
17,18. To the best of our knowledge, although metabolomic
approaches have been employed for the biochemical characterization of metabolic changes in blood
19 or urine
20
triggered by gut microbiota, there is little knowledge about the intestinal luminal metabolome, which may be
sourceofmetabolitesinbloodandurine.Nicholsonandco-workers
21,22suggestedanalyzingintestinalmicrobial-
host metabolic interactions by metabolomic analysis using
1H nuclear magnetic resonance (NMR) spectroscopy
and ultra-performance liquid chromatography-mass spectrometry (UPLC-MS). The dynamics of fecal volatile
metabolites were changed by the administration of prebiotics and probiotics based on the results of gas chro-
matography mass spectrometry solid phase micro-extraction
23. However, these metabolome analyses focused on
specific metabolites, such as bile acids metabolism, and did not focus on a wide spectrum of intestinal luminal
metabolites. In addition, in these studies
21,22, they analyzed metabolome-containing bacterial intercellular meta-
bolites because the sample was prepared by sonication of feces. For clarifying the relationship between health/
diseaseandintestinalbacterialmetabolites,onlyfreebacterialmetabolitesintheintestinalluminalcontentshould
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taken food ingredients into consideration. Therefore, there is little
information available regarding the intestinal luminal metabolome
produced by intestinal microbiota.
Large-scale metabolome analysis methods are based on gas chro-
matography mass spectrometry (GC-MS), liquid chromatography
massspectrometry(LC-MS),NMR,Fourier-transformioncyclotron
resonance mass spectrometry, and capillary electrophoresis mass
spectrometry (CE-MS). Each of these methods has its own merits
and demerits. For example, although NMR can identify metabolites
exactly, its sensitivity is lower than that of other methods. GC-MS is
suitable only for volatile metabolites. Although LC-MS detects rela-
tivelywide-spectrummetabolites,chromatographicseparationisnot
satisfactory. The utilityofCE-MS inmetabolomics has recentlybeen
recognized; this is more sensitive and detects a wider spectrum than
LC-MS
24. In particular, CE with time-of-flight mass spectrometry
(CE-TOFMS) is a novel strategy for analyzing and differentially dis-
playing metabolic profiles
25. The major advantages of CE-TOFMS
include its extremely high resolution, high throughput, and ability
to simultaneously quantify all charged low-molecular-weight com-
pounds in a sample. Because this can determine the majority of
metabolic intermediates, many metabolites in the cellular/bacterial
metabolicpathwayscanbethusobserved
18.Acomprehensiveunder-
standing of the metabolite profile in the intestinal lumen by using
CE-TOFMS would be critical for elucidating the host-intestinal bac-
terial interaction.
Here, using CE-TOFMS, we analyzed the colonic luminal meta-
bolome obtained from GF mice and ex-germ free (Ex-GF) mice,
divided from brothers bred from same parents, harboring Specific
pathogen-free (SPF) mice intestinal microbiota and demonstrated
the large effect of intestinal microbiota on the colonic luminal
metabolome.
Results
The difference in colonic luminal metabolome between GF and
Ex-GF mice. From the colonic luminal metabolome in both of GF
and Ex-GF mice, CE-TOFMS identified 179 metabolites. Principal
component analysis (PCA) and hierarchical clustering, showing
patterns of metabolites, are shown in Fig. 1a and b, respectively. A
remarkable difference was observed in the colonic luminal meta-
bolome between GF mice and Ex-GF mice, showing that intestinal
microbiota highly influences the colonic luminal metabolome, as
Figure 1 | The difference in the colonic metabolomes between GF mice and Ex-GF mice. (a) PCA of the profiling data from the colonic metabolome.
(b) Hierarchical clustering showing patterns of metabolites. Red and green indicate high and low concentrations of metabolites, respectively. (c) Venn
diagram of the metabolites noted in the pellet and the colonic metabolome. (d) The number of colonic luminal metabolites in the group GF . Ex2GF,
GF<Ex2GF, and GF . Ex2GF.
www.nature.com/scientificreports
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detected.
Of the 179 metabolites in the colonic luminal metabolome, 131
metabolites were common to those detected from the pellet, and 48
metabolites were detected only from the colonic luminal metabo-
lome (Fig. 1c). Further, 119 metabolites were detected only from the
pellet (Supplemental Table S1), indicating that these were perfectly
absorbed in the upper part of the intestine. Of the 179 metabolites
in the colonic luminal metabolome, 48 metabolites were present in
significantly (p , 0.05) higher concentrations and/or incidence in
the GF mice than in the Ex-GF mice (group GF . Ex-GF), 77 meta-
bolites were present in significantly (p , 0.05) lower concentrations
Figure 2 | Classificationofmetabolitesdetectedfrommiceandpellets. Themetabolitesineachgroupareclassifiedasfollows:(A)Metabolitesproduced
by host and absorbed/hydrolyzed by colonic microbiota. (B) Metabolites produced by host or derived from pellet and absorbed/hydrolyzed by colonic
microbiota.(C)Metabolitesproducedbyhostandnotinfluencedbycolonicmicrobiota.(D)Metabolitesproducedbyhostorderivedfrompelletandnot
influenced by colonic microbiota. (E) Metabolites produced by colonic microbiota. (F) Metabolites produced by colonic microbiota or derived from
pellet and the absorption of which was possibly inhibited in the colon. (G) Ingredients in the pellet absorbed by the host.
www.nature.com/scientificreports
SCIENTIFIC REPORTS | 2 : 233 | DOI: 10.1038/srep00233 3and/or incidence in the GF mice than in the Ex-GF mice (group GF
, Ex-GF), and 56 metabolites showed no differences in the concen-
tration or incidence between GF and Ex-GF mice (group GF < Ex-
GF) (Fig. 1d). These metabolites were classified into 10 categories as
follows:amino acid (AA) derivatives, AA metabolismrelatives, basic
AAs, carbohydrate metabolism intermediates, central carbon meta-
bolismintermediates,co-enzyme/co-enzyme derivatives,lipidmeta-
bolism relatives, nucleic acid relatives, peptides, and others. The
details of the metabolites belonging to group GF . Ex-GF, group
GF < Ex-GF, and group GF , Ex-GF are shown in Supplemental
Table S2 and Supplemental Fig. S1, Supplemental Table S3 and
Supplemental Fig. S2, and Supplemental Table S4 and Supple-
mentalFig. S3, respectively. In the group GF. Ex-GF, carbohydrate
metabolism intermediates, such as glucosamine, were characterist-
ically detected. In the group GF < Ex-GF, basic AAs and peptides
were characteristically detected. In the group GF , Ex-GF, AA
metabolism relatives, central carbon metabolism intermediated,
co-enzyme/co-enzyme derivatives, and others (unclassified) were
characteristically detected.
Comparison of colonic luminal metabolites in GF and Ex-GF
mice. For further understanding, we classified metabolites into 7
groups as follows: (A) metabolites that belong to group GF .
Ex-GF but not detected from the pellet, (B) metabolites that belong
to group GF . Ex-GF and detected from the pellet, (C) metabolites
that belong to group GF < Ex-GF but not detected from the pellet,
(D)metabolitesthatbelongtogroupGF<Ex-GFanddetectedfrom
the pellet, (E) metabolites that belong to group GF , Ex-GF but not
detected from the pellet, (F) metabolites that belong to group GF ,
Ex-GF and detected from the pellet, and (G) metabolites (ingre-
dients) detected from only the pellet (Fig. 2). Of the 179 meta-
bolites in the colonic luminal metabolome, the concentration of 60
metabolites involved in primary metabolisms could be measured;
further, the absolute concentration of these metabolites in the
pellet, colonic lumen of GF mice, and that of Ex-GF mice were
compared (Fig. 3). In Fig. 3, we have shown the estimated value for
the metabolite’s (ingredient) concentration of the pellet in the
colonic lumen. The average solid content of the pellet and colonic
contentwere93.45%and35.06%,respectively.Weconsiderthatthe
pelletreachedthecolonwithdilutionbydrinkingwateranddigestive
juices without absorption/hydrolyzation; we estimated that the
pellet was diluted 2.665-fold by drinking water and digestive juices
(2.665593.45/35.06). Thus, the metabolite concentration of the
pellet was calculated using the following formula:
Equivalent value (nmol/g)5value measured by CE-TOFMS/2.665
Eighteen metabolites belonging to group A were those derived
from host/digestion and absorbed/hydrolyzed by intestinal micro-
biota. Twenty-eight metabolites belonging to group B were derived
from the pellet or host/digestion and absorbed/hydrolyzed by in-
testinal microbiota. The concentrations of hydroxyprolin, Pro, Thr,
Arg, and uridine in the intestinal lumen of GF mice were obviously
higher than those in the pellet (Fig. 3 upper panel). In contrast,
the concentrations of creatinine, Asn, choline, and inosine in the
intestinal lumen of GF mice were equal or lower than those in the
pellet(Fig.3upperpanel).ThirteenmetabolitesbelongingtogroupC
were derived from host/digestion and not absorbed/hydrolyzed by
intestinal microbiota. In this group, peptides were characteristically
detected. Forty-three metabolites belonging togroup D were derived
from pellet or host/digestion and not absorbed/hydrolyzed by in-
testinal microbiota. In this group, basic AAs were characteristically
detected.TheconcentrationoftheseAAs,exceptTrp,inGFmicewas
obviously higherthan that in the pellet (Fig. 3 middle panel). SCFAs,
i.e., butyric acid and propionic acid, were characteristically detected.
Seventeen metabolites belonging to group E were those produced by
intestinal microbiota. Sixty metabolites belonging to group F were
those produced by intestinal microbiota or derived from the pellet
and their absorption/hydrolyzation by intestinal microbiota was
inhibited. However, to the best of our knowledge, no report has
described that intestinal microbiota suppress the absorption/hydro-
lyzation of low-molecular metabolites (ingredients) derived from
foods. Therefore, we believe that the metabolites in groups
E and F were simply produced by intestinal microbiota. Primary
amines, b-Ala, tyamine, c-aminobutyric acid (GABA), and PAs
(putrescine, spermidine, and cadaverine), along with the bases aden-
ine, guanine, cytosine, and uracil, were characteristically detected in
group F (Fig. 3 bottom panel).
Colonic microbiota of Ex-GF mice. The PCA diagram and
dendrogram of colonic microbiota of Ex-GF mice based on the T-
RFLP pattern are shown in Fig. 4a and 4b, respectively. The colonic
microbiota of Ex-GF mice were divided into two clusters—Ex-GF 1,
2, 3, and 4 (first sons) and Ex-GF 5, 6, and 7 (second sons)—along
with the result of PCA of the colonic luminal metabolome (Fig. 1a).
The position of Ex-GF 7 was separated from the other brothers from
the same mother in both PCA and the dendrogram of colonic
microbiota as well as the PCA of the metabolome, indicating that
intestinal microbiota influenced the intestinal luminal metabolome.
The number of predominant bacterial genera and groups was
determined by real-time PCR. Figure 4c shows the cell numbers
for predominant bacterial genera and groups in the Ex-GF 1–4
(first sons) and Ex-GF 5–7 (second sons) generations. The popula-
tions of Enterococcus spp. and Lactobacillus spp. in Ex-GF 1–4 were
significantly higher than those in Ex-GF 5–7 (p , 0.05). The
population of Enterobacteriaceae in Ex-GF 1–4 tended to be lower
than that in Ex-GF 5–7 (p50.082).
Relationships between predominant bacteria and metabolites.
The relationship between predominant bacteria populations and
the concentration of metabolites that there are difference between
Ex-GF 1–4 (first sons) and Ex-GF 5–7 (second sons) is shown in
Table 1. The number of Enterobacteriaceae, Enterococcus spp., and
Lactobacillusspp.waspositivelycorrelatedwiththeconcentrationof
9,1,and1ofthe25metabolites,respectively.Incontrast,thenumber
of Enterobacteriaceae, Enterococcus spp., and Lactobacillus spp. was
inversely correlated with the concentration of 1, 4, and 20 out of
the 25 metabolites, respectively. The number of Bacteroides spp.,
Bifidobacterium spp., Clostridium cluster IV, Clostridium subcluster
XIVa, and Prevotella spp. was not correlated with the concentration
of any of the metabolites.
Discussion
In this study, by comparing the colonic luminal metabolome of GF
mice and Ex-GF mice using CE-TOFMS, we obtained anovel profile
ofnumerousmetabolitesintheintestinallumenwithoutcomparison
in the past
21–23. In other studies, 10–60 metabolites have been
detected from fecal samples by NMR and LC-MS, but in this study,
179 metabolites were detected by CE-TOFMS, which is 5 times
higher than that of past studies. This is attributable to the extremely
high resolution provided by CE-TOFMS
24,25. The present results
indicate that CE-TOFMS is the most suitable method for compre-
hensiveandlarge-scalemetabolomeanalysisintheintestinalluminal
environment.Understandingtheinputofmetabolitesfromthepellet
enabled us to consider the impact of intestinal microbiota on the
colonicluminalmetabolome.Wecomparedtheresultsofthepresent
study with the general knowledge in our field as follows.
Almost all basic AAs—except Pro, Thr, Asn, and Arg—belonged
to group GF < Ex-GF (Supplemental Table S3) and were obviously
presentinhigherconcentrationsinthecoloniclumenofbothGFand
Ex-GF mice than in the pellet, indicating that free basic AAs in
colonic lumen are not derived from the pellet directly, but are pro-
duced by the digestion of proteins contained in the pellet and/or
intestinal mucus in the upper part of the intestine. This also suggests
www.nature.com/scientificreports
SCIENTIFIC REPORTS | 2 : 233 | DOI: 10.1038/srep00233 4Figure 3 | Absolute quantitative comparison of metabolites in the pellet and the colonic lumen of GF mice and Ex-GF mice (nmol/g of feces).
Metabolites belonging to group GF . Ex2GF, GF < Ex2GF, and GF , Ex2GF are shown in the upper, middle, and bottom panels, respectively.
Dataarerepresentedasmean6SEM.Estimatedvaluesofpelletingredientsinthecoloniclumenarecalculatedasfollows:Estimatedvaluesofingredients
(nmol/g)5measured concentration in pellet by CE-TOFMS/2.665 [5pellet solid content (93.451%)/solid content of colonic content (33.06%)].
www.nature.com/scientificreports
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notentirelyabsorbedthere,resultingintheentryofunabsorbedAAs
into the colon. We have believed that AAs are utilized as sources of
nitrogen by intestinal microbiota; for example, AAs arising from
digestion are deaminated/degraded by intestinal microbiota, and
NH3degraded fromAAs maybeutilized formicrobial cellsynthesis,
while microbial metabolism of AAs results in the production of
SCFAs and gases in the colon
26,27. However, 15 basic AAs—except
Pro, Thr, Asn, and Arg—were not significantly absorbed/degraded
by the intestinal microbiota. Based on these results, we consider that
the theory concerning the relationship between AAs and intestinal
microbiota in the colon needs to be reassessed. Further studies are
required to clarify why intestinal bacteria utilize only Pro, Thr, Asn,
and Arg.
Althoughmostpeptides werenotabsorbed/degradedbyintestinal
microbiota similar to most of the AAs, 4 peptides—Gly-Asp, c-Glu-
2-aminobutanoic acid, ophthalmic acid, and S-lactoylglutathione—
wereproducedbyhost/digestionand/ordegradedperfectlybyintest-
inal microbiota, while 2 peptides, Arg-Glu and Ala-Ala, were pro-
duced by intestinal microbiota (Supplemental Fig. S4). Interestingly,
c-Glu-2-aminobutanoicacidand ophthalmicacidare biosynthesized
by hepatic glutathione consumption induced by oxidative stress,
with serum ophthalmic acid being a sensitive indicator of hepatic
glutathione depletion
28. After birth, oxygen in the colon appears to
be consumed first by colonized aerobes, such as Enterobacteriaceae
and Streptococcus
29; therefore, we suppose that a little oxygen exists
in the colonic lumen in GF mice and colonocytes are influenced by
oxidative stress. Arg-Gln inhibits retinal neovascularization in the
Figure 4 | ColonicmicrobiotainGFmiceandEx2GFmice. (a)PCAoftheprofiling datafromcolonic microbiota.(b)ThedendrogramoftheT-RFLP
profilesofcolonicmicrobiotafromGFmiceandEx-GFmice.(c)ThenumberofpredominantbacterialgeneraandgroupsintheEx-GF1,2,3,and4(first
sons) and Ex-GF 5, 6, and 7 (second sons) clusters.
www.nature.com/scientificreports
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30, indicating that
intestinal microbiota produce functional peptides.
Most primary amines biosynthesized by decarboxylation from
AAs have physiological functions. Although no differences in the
concentrations of most of the precursors were noted between the
GF mice and the Ex-GF mice or even if the concentrations of
the precursors in the GF mice were higher than those in the Ex-GF
mice, the concentrations of all primary amines in the Ex-GF mice
were higher than those in the GF mice (Supplemental Fig. S5). In the
colon, b-Ala, cadaverine, putrescine, tyramine, and GABA are syn-
thesized by colonic bacterial decarboxylase from free AAs, Asp, Lys,
ornithine, Tyr, and Glu, respectively. These are also biosynthesized
in the host cells. Further research is warranted in order to confirm
whether a certain proportion of these primary amines produced by
intestinal microbiota are absorbed by colonocytes, with the remain-
ing portion circulating in the blood.
PAs, such as putrescine, spermidine, and spermine, are one of
the most important metabolites produced by intestinal microbiota
affecting the health and disease of the host
31. PAs are organic cations
required for cell growth and differentiation and for the synthesis of
DNA, RNA, and proteins
32; they are constantly absorbed as energy
sources from the intestinal lumen
33. PAs have many functions, such
as the maturation and maintenance of intestinal mucosal barrier
34,35,
anti-inflammatory actions
36, antimutagenicity
37, and autophagy
38.
Although we have demonstrated that colonic microbiota are in-
volved in regulating colonic luminal PA concentrations
39,40, which
entity influenced colonic luminal PA concentrations to a greater
extent—intestinal microbiota or colonocytes—remained unclear.
This study demonstrates that the intestinal luminal concentrations
of putrescine and spermidine are mainly dependent on colonic
microbiota. However, spermine concentrations were not influenced
by intestinal microbiota. Spermine has the strongest physiological
functionandtoxicityamongPAs,anditsconcentrationappearstobe
strictly controlled by both colonic microbiota and colonocytes. We
mapped the results for each PA onto the PA metabolic pathways of
Escherichia coli (Supplemental Fig. S6). Here, agmatine was not
detected although Arg decarboxylation is the dominant pathway
for PA biosynthesis in human gut microbiota
41. On the other hand,
the pathway via which putrescine is decarboxylated from ornithine
produced from Arg appeared to be available. Further studies are
required to clarify the PA metabolic pathways of intestinal microbiota.
Prostaglandin E2 (PGE2) was detected only in Ex-GF mice. PGE2
isaninterleukin-10(IL-10)-independentinnateimmunesuppressor.
A recent study reported PGE2 and suppressor of cytokine signalling
1 (SOCS1) as an essential mediator of immune tolerance in the
intestine, andthat these may actas analternative intestinal tolerance
mechanism distinct from IL-10 and regulatory T cells by potentially
interacting together
42. Therefore, we suppose that the intestinal
microbiota contain activation factors for innate immunity, similar
to inflammation.
These findings were reconfirmed by the present CE-TOFMS ana-
lysis.SCFAs, such aspropionic acidand butyric acid, thatbelonged to
group E are produced by intestinal microbiota. Urea was detected
only from GF mice, showing that urea is hydrolyzed by the urease of
intestinal microbiota
43. Taurocholicacid, a major conjugated bileacid
inmice
44,wasdetectedfromtheintestinallumenofbothGFmiceand
Ex-GF mice,althoughthe concentrationsoftaurineandcholicacidin
the colonic lumen of Ex-GF mice were significantly higher than those
in GF mice, proving that conjugated bile acids not absorbed in the
ileum are reconjugated by intestinal microbiota (Supplemental Fig.
S7). CE-TOFMS could not detect secondary bile acids such as deoxy-
cholic acid, a strongly toxic acid. However, since the reconjugation of
bile acids is the first step in the production of secondary bile acids,
this is one of the harmful influences of intestinal microbiota.
We tried to test the association between the number of clusters of
colonicmicrobiotaofEx-GFmice(i.e.,Ex-GF1-4andEx-GF5-7)and
the concentration of metabolites, using genera- or group-specific pri-
mer sets in order to comprehensively analyze uncultured bacteria.
Enterobacteriaceae, Enterococus spp., and Lactobacillus spp. were
found to influence metabolite concentrations. To the best of our
knowledge, this finding is novel because none of the published studies
on microbiota and metabolite correlation have taken into account
uncultured bacteria. Especially, Enterobacteriaceae thrive in an in-
flamed environment
45,46 and are known to be present in increased
amounts in the elderly
47. The relationship between Enterobacteriaceae,
metabolites, and inflanmmation/ageing warrants further study.
These discussions center on a comparison between general know-
ledgeandthedataobtainedinthepresentstudy.However,theeffects
of almost all metabolites in the colon are unclear. Even for GABA,
which is known as a neurotransmitter, it remains unknown whether
colonic GABA significantly affects health or disease. Although sev-
eral metabolites might not contribute to health and disease, some
metabolites might be important findings for researchers in another
field.Weconsiderthatthesedatahaveimplicationsforresearchersin
anumberoffields,suchasmedicine,immunology,physiology,phar-
macology, bacteriology, nutrition, and life sciences.
Methods
Mice.GermfreeBALB/cmicewerepurchasedoriginallyfromJapanCleaInc.(Tokyo,
Japan), and were bred in the Department of Infectious Diseases, Tokai University
SchoolofMedicine,Kanagawa,Japan.Wedividedmalemicebredfromsister-brother
mating into two groups, GF mice (first sons: GF 1–3, second sons: GF-4–6) and
Ex-GF mice (first sons: Ex-GF 1–4, Ex-GF 5–7), twice (Supplemental Fig. S8). They
were housed in Trexler-Type flexible film plastic isolators with sterilized Clean tip
(CLEA Japan, Inc., Tokyo) as bedding and given sterilized water and sterilized
commercial CL-2 pellets (CLEA Japan, Inc.) ad libitum. The diet was sterilized with
an autoclave (121uC, 30 min). Surveillance for bacterial contamination was
performed by periodic bacteriological examination of feces throughout the
experiments. Ex-GF mice were inoculated at 4 weeks of age into the stomach by a
metal catheter with 0.5 mL of a 10
21 suspension of feces obtained from SPF BALB/c
mice. The protocols approved by the Kyodo Milk Animal Use Committee (Permit
Number: 2009-02) and all experimental procedures were performed according to the
guidelines of the Animal Care Committee of Tokai University.
Preparation of colonic luminal metabolome. Seven-week-old mice were sacrificed
by cervical dislocation and the colon was resected via an abdominal incision. The
colon was opened using a longitudinal incision, and the colonic contents were
obtained and stored at –80uC until use. Frozen colonic contents (approximately
100 mg) were diluted 5-fold with Dulbecco’s Phosphate Buffered Saline (D-PBS)
(GIBCO) and extracted three times by intense mixing for 1 min and letting them
stand for 5 min on the icebox. At 1 min after extraction, the upper aqueous portion
without precipitation at the bottom was collected and centrifuged (12,000 3 g for
10 minat4uC),and100 mLofsupernatant wascentrifugallyfiltered througha5-kDa
cutoff filter Ultrafree-MC (Millipore). The filtrate was stored at –80uC until use. We
confirmedtheabsenceofintracellularmetabolitesderivedfrombacteriadestroyedby
this extraction, in the supernatant (Supplemental Figure S9). Because this extraction
was conducted to obtain only water-soluble metabolites, non-water-soluble
metabolites were not extracted efficiently. Even if the extraction efficiencies for each
metabolitevary,thisextractionmethodissuitable forrelative quantification, sinceall
thesampleswereextractedusingthesameprocedureatthesametime.Theprecipitate
was washed by 1 mL D-PBS twice, stored at –80uC, and used for the analysis of
intestinal microbiota.
Preparation of pellet for metabolome analysis. Sterilized commercial CL-2 pellets
(CLEA Japan, Inc.) was crushed by mortar and prepared as described in the colonic
luminal metabolome section above.
CE-TOFMS.Themetabolomics measurementanddataprocessing wasperformedas
describedpreviouslywithanAgilentCapillaryElectrophoresisSystem
48.Then,20 mL
of fecal solution was mixed with 80 mL of 250 mM each of methionine sulphone
(MetSul) and CSA. The measurement of extracted metabolites in both positive and
negative modes was performed by using commercial electrophoresis buffer (Solution
ID H3301-1001 for the cation mode and H3302-1021 for the anion mode; Human
Metabolome Technologies Inc., Tsuruoka, Japan). The alignment of detected peaks
was performed according to the m/z value and normalized migration time. Then,
peak areas were normalized against those of the internal standards MetSul and D-
camphor-10-sulfonic acid (CSA) for cationic and anionic metabolites, respectively.
Annotation tables were produced from measurement of standard compounds and
were aligned with the datasets according to similar m/z value and normalized
migration time. We confirmed that this method has sufficient reproducibility for
analysis of the intestinal luminal metabolome by using human feces (Supplemental
Figure S10). Principal component analysis (PCA) and clustering analysis was
processed by SIMCA-P1 (Umetrics), respectively.
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centrifugationintheprocedureofthepreparationofthecolonicluminalmetabolome
was washed by 1 mL D-PBS twice, stored at –80uC, and used for the analysis of
intestinal microbiota. This bacterial DNA was isolated using the methods described
by Matsuki et al.
49 with some modifications. Briefly, bacterial suspension with lysis
bufferwastreatedat 70uCfor10 minin awaterbath andvortexed vigorously for60s
with a Micro Smash MS-100 (Tomy Digital Biology Co., Ltd., Tokyo, Japan) at
4,000 rpm.
T-RFLP analysis. T-RFLP analysis was performed as described in our previous
report
40 with some modifications. Briefly, 27F primer (59-AGAGTT-
TGATCCTGGCTCAG-39)labelledatthe59-endwith6-carboxyfluoresceinwasused
instead of the 529F primer. Then 50 ng of the purified PCR product was digested
using0.25unitsofHaeIIIorAluI(Takara)at37uCfor3 h.ThePCRproductsandthe
restrictiondigestproductswerepurifiedbyGenElutePCRClean-UpKit(Sigma).The
terminal-restriction fragment (T-RF) length was determined using a 1200LIZ
standard size marker (Applied Biosystems) in a 3130 Genetic Analyzer (Applied
Biosystems) and with the aid of Gene Mapper software v.4.0 (Applied Biosystems).
PCA was processed by SIMCA-P1 (Umetrics).
Real-timePCRforquantitativedeterminationofbacterialcellnumbers.Real-time
PCR for the quanti¢cation of predominant bacterial genera and groups was
performed using the StepOne Real-time PCR system (Applied Biosystems), as
described in our previous report
50. The primer sets used are shown in Supplemental
Table S5 as well as in our previous report
31.
Data analysis and statistics. PCA in metabolome and colonic microbiota was
processed by SIMCA-P1 (Umetrics). Clustering analysis in metabolome was
processed by MATLAB 2008a (MathWorks, MA, USA). Differences in relative
quantitybetween GFmiceand Ex-GFmice wereevaluated forindividual metabolites
by Welch’s t-test. The relationship between metabolite concentrations and the
number of predominant bacterial cells was examined by linear regression analysis.
The incidences of the individual metabolites in GF mice and Ex-GF mice were
comparedbyFisher’sexacttest.StatMateIV(ATMSCo.Ltd.,Tokyo,Japan)wasused
to conduct these analyses.
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